Signatera Assessment in Early-Stage Endometrial Cancer
Signatera Assessment in Early-Stage Endometrial Cancer
Not yet recruiting · NCT07339384 · Registry updated 2026-06-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Signatera Assessment in Early-Stage Endometrial Cancer | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine disorder | Not yet recruiting | Not applicable | 2026-06-17 | NCT07339384 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Natera, Inc. | 45 |
12 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Allegheny Health | Pittsburgh | United States | 2 |
| Atrium Health Levine Cancer | Charlotte | United States | 13 |
| Cleveland Clinic | Cleveland | United States | 21 |
| Duke University | Durham | United States | 45 |
| New York University | New York | United States | 26 |
| Ohio State University Wexner Medical Center | Columbus | United States | 36 |
| University of Alabama at Birmingham Hospital | Birmingham | United States | 3 |
| University of California, Los Angeles | Los Angeles | United States | 142 |
| University of California, San Diego | La Jolla | United States | 38 |
| University of Chicago | Chicago | United States | 312 |
| University of Miami | Miami | United States | 22 |
| University of Minnesota | Minneapolis | United States | 325 |